| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |